Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,500 35 40 35 40 B-lower_bound
/ 40 41 40 41 I-lower_bound
mm^3 41 45 41 45 I-lower_bound
, 46 47 46 47 O
equivalent 48 58 48 58 O
to 59 61 59 61 O
Common 62 68 62 68 O
Toxicity 69 77 69 77 O
Criteria 78 86 78 86 O
( 87 88 87 88 O
Common 88 94 88 94 O
Terminology 95 106 95 106 O
Criteria 107 115 107 115 O
for 116 119 116 119 O
Adverse 120 127 120 127 O
Events 128 134 128 134 O
[ 135 136 135 136 O
CTCAE 136 141 136 141 O
] 141 142 141 142 O
version 143 150 143 150 O
[ 151 152 151 152 O
v 152 153 152 153 O
] 153 154 153 154 O
3.0 155 158 155 158 O
) 158 159 158 159 O
grade 160 165 160 165 O
1 166 167 166 167 O

Alkaline 0 8 168 176 B-clinical_variable
phosphatase 9 20 177 188 I-clinical_variable
= 21 22 189 190 O
< 22 23 190 191 O
2.5 24 27 192 195 B-upper_bound
x 28 29 196 197 I-upper_bound
ULN 30 33 198 201 B-clinical_variable
( 34 35 202 203 O
CTCAE 35 40 203 208 O
v 41 42 209 210 O
3.0 43 46 211 214 O
grade 47 52 215 220 B-lower_bound
0 53 54 221 222 I-lower_bound
- 54 55 222 223 O
1 55 56 223 224 B-upper_bound
) 56 57 224 225 O

All 0 3 226 229 O
patients 4 12 230 238 O
must 13 17 239 243 O
have 18 22 244 248 O
undergone 23 32 249 258 O
complete 33 41 259 267 B-treatment
hysterectomy 42 54 268 280 I-treatment
and 55 58 281 284 O
bilateral 59 68 285 294 B-treatment
salpingo 69 77 295 303 I-treatment
- 77 78 303 304 I-treatment
oophorectomy 78 90 304 316 I-treatment
at 91 93 317 319 O
the 94 97 320 323 O
time 98 102 324 328 O
of 103 105 329 331 O
original 106 114 332 340 O
therapy 115 122 341 348 B-treatment
for 123 126 349 352 O
their 127 132 353 358 O
uterine 133 140 359 366 B-cancer
carcinoma 141 150 367 376 I-cancer

Bilirubin 0 9 377 386 B-clinical_variable
= 10 11 387 388 O
< 11 12 388 389 O
1.5 13 16 390 393 B-upper_bound
x 17 18 394 395 I-upper_bound
ULN 19 22 396 399 I-upper_bound
( 23 24 400 401 O
CTCAE 24 29 401 406 O
v 30 31 407 408 O
3.0 32 35 409 412 O
grade 36 41 413 418 O
1 42 43 419 420 O
) 43 44 420 421 O

Creatinine 0 10 422 432 B-clinical_variable
= 11 12 433 434 O
< 12 13 434 435 O
institutional 14 27 436 449 B-clinical_variable
upper 28 33 450 455 I-clinical_variable
limit 34 39 456 461 I-clinical_variable
normal 40 46 462 468 I-clinical_variable
( 47 48 469 470 I-clinical_variable
ULN 48 51 470 473 I-clinical_variable
) 51 52 473 474 I-clinical_variable
, 52 53 474 475 O
CTCAE 54 59 476 481 O
v 60 61 482 483 O
3.0 62 65 484 487 O
grade 66 71 488 493 O
0 72 73 494 495 O

Neuropathy 0 10 496 506 B-chronic_disease
( 11 12 507 508 I-chronic_disease
sensory 12 19 508 515 I-chronic_disease
and 20 23 516 519 I-chronic_disease
motor 24 29 520 525 I-chronic_disease
) 29 30 525 526 I-chronic_disease
= 31 32 527 528 O
< 32 33 528 529 O
CTCAE 34 39 530 535 B-clinical_variable
v 40 41 536 537 O
3.0 42 45 538 541 O
grade 46 51 542 547 B-upper_bound
1 52 53 548 549 I-upper_bound

Patients 0 8 550 558 O
may 9 12 559 562 O
have 13 17 563 567 O
received 18 26 568 576 O
prior 27 32 577 582 B-treatment
hormone 33 40 583 590 I-treatment
therapy 41 48 591 598 I-treatment
and/or 49 55 599 605 O
systemic 56 64 606 614 B-treatment
chemotherapy 65 77 615 627 I-treatment
; 77 78 627 628 O
such 79 83 629 633 O
therapy 84 91 634 641 O
must 92 96 642 646 O
have 97 101 647 651 O
been 102 106 652 656 O
completed 107 116 657 666 O
at 117 119 667 669 O
least 120 125 670 675 O
6 126 127 676 677 B-lower_bound
months 128 134 678 684 I-lower_bound
prior 135 140 685 690 I-lower_bound
to 141 143 691 693 O
study 144 149 694 699 O
entry 150 155 700 705 O
and 156 159 706 709 O
the 160 163 710 713 O
patient 164 171 714 721 O
has 172 175 722 725 O
clear 176 181 726 731 O
evidence 182 190 732 740 O
of 191 193 741 743 O
disease 194 201 744 751 O
subsequent 202 212 752 762 O
to 213 215 763 765 O
such 216 220 766 770 O
therapy 221 228 771 778 O

Patients 0 8 779 787 O
must 9 13 788 792 O
have 14 18 793 797 O
Gynecologic 19 30 798 809 B-clinical_variable
Oncology 31 39 810 818 I-clinical_variable
Group 40 45 819 824 I-clinical_variable
( 46 47 825 826 I-clinical_variable
GOG 47 50 826 829 I-clinical_variable
) 50 51 829 830 I-clinical_variable
performance 52 63 831 842 I-clinical_variable
status 64 70 843 849 I-clinical_variable
0 71 72 850 851 B-lower_bound
, 72 73 851 852 O
1 74 75 853 854 O
, 75 76 854 855 O
or 77 79 856 858 O
2 80 81 859 860 B-upper_bound

Patients 0 8 861 869 O
must 9 13 870 874 O
have 14 18 875 879 O
a 19 20 880 881 O
biopsy 21 27 882 888 B-treatment
with 28 32 889 893 O
histologically 33 47 894 908 O
confirmed 48 57 909 918 O
diagnosis 58 67 919 928 O
of 68 70 929 931 O
recurrent 71 80 932 941 O
endometrial 81 92 942 953 B-cancer
cancer 93 99 954 960 I-cancer
confined 100 108 961 969 O
to 109 111 970 972 O
the 112 115 973 976 O
pelvis 116 122 977 983 O
and/or 123 129 984 990 O
vagina 130 136 991 997 O

Patients 0 8 998 1006 O
must 9 13 1007 1011 O
have 14 18 1012 1016 O
an 19 21 1017 1019 O
estimated 22 31 1020 1029 B-clinical_variable
survival 32 40 1030 1038 I-clinical_variable
greater 41 48 1039 1046 O
or 49 51 1047 1049 O
equal 52 57 1050 1055 O
to 58 60 1056 1058 O
3 61 62 1059 1060 B-lower_bound
months 63 69 1061 1067 I-lower_bound

Patients 0 8 1068 1076 O
must 9 13 1077 1081 O
have 14 18 1082 1086 O
endometrial 19 30 1087 1098 B-cancer
carcinoma 31 40 1099 1108 I-cancer
including 41 50 1109 1118 O
endometrioid 51 63 1119 1131 B-cancer
adenocarcinoma 64 78 1132 1146 I-cancer
, 78 79 1146 1147 O
adenocarcinoma 80 94 1148 1162 O
with 95 99 1163 1167 O
squamous 100 108 1168 1176 O
differentiation 109 124 1177 1192 O
, 124 125 1192 1193 O
mucinous 126 134 1194 1202 B-cancer
adenocarcinoma 135 149 1203 1217 I-cancer
, 149 150 1217 1218 O
squamous 151 159 1219 1227 B-cancer
cell 160 164 1228 1232 I-cancer
carcinoma 165 174 1233 1242 I-cancer
, 174 175 1242 1243 O
mixed 176 181 1244 1249 B-cancer
carcinoma 182 191 1250 1259 I-cancer
, 191 192 1259 1260 O
undifferentiated 193 209 1261 1277 B-cancer
carcinoma 210 219 1278 1287 I-cancer
, 219 220 1287 1288 O
clear 221 226 1289 1294 B-cancer
cell 227 231 1295 1299 I-cancer
adenocarcinoma 232 246 1300 1314 I-cancer
, 246 247 1314 1315 O
and 248 251 1316 1319 O
serous 252 258 1320 1326 B-cancer
adenocarcinoma 259 273 1327 1341 I-cancer
histologies 274 285 1342 1353 O

Patients 0 8 1354 1362 O
must 9 13 1363 1367 O
have 14 18 1368 1372 O
no 19 21 1373 1375 O
evidence 22 30 1376 1384 O
of 31 33 1385 1387 O
extrapelvic 34 45 1388 1399 B-chronic_disease
disease 46 53 1400 1407 I-chronic_disease

Patients 0 8 1408 1416 O
who 9 12 1417 1420 O
have 13 17 1421 1425 O
a 18 19 1426 1427 O
significant 20 31 1428 1439 O
history 32 39 1440 1447 O
of 40 42 1448 1450 O
cardiac 43 50 1451 1458 B-chronic_disease
disease 51 58 1459 1466 I-chronic_disease
, 58 59 1466 1467 O
i.e. 60 64 1468 1472 O
, 64 65 1472 1473 O
uncontrolled 66 78 1474 1486 O
hypertension 79 91 1487 1499 B-chronic_disease
, 91 92 1499 1500 O
unstable 93 101 1501 1509 B-chronic_disease
angina 102 108 1510 1516 I-chronic_disease
, 108 109 1516 1517 O
congestive 110 120 1518 1528 B-chronic_disease
heart 121 126 1529 1534 I-chronic_disease
failure 127 134 1535 1542 I-chronic_disease
, 134 135 1542 1543 O
or 136 138 1544 1546 O
uncontrolled 139 151 1547 1559 O
arrhythmias 152 163 1560 1571 B-chronic_disease
within 164 170 1572 1578 O
6 171 172 1579 1580 B-upper_bound
months 173 179 1581 1587 I-upper_bound
of 180 182 1588 1590 O
registration 183 195 1591 1603 O

Patients 0 8 1604 1612 O
who 9 12 1613 1616 O
have 13 17 1617 1621 O
received 18 26 1622 1630 O
previous 27 35 1631 1639 B-treatment
vaginal 36 43 1640 1647 I-treatment
, 43 44 1647 1648 O
pelvic 45 51 1649 1655 B-treatment
, 51 52 1655 1656 O
or 53 55 1657 1659 O
abdominal 56 65 1660 1669 B-treatment
irradiation 66 77 1670 1681 I-treatment

Patients 0 8 1682 1690 O
who 9 12 1691 1694 O
have 13 17 1695 1699 O
undergone 18 27 1700 1709 O
complete 28 36 1710 1718 O
surgical 37 45 1719 1727 B-treatment
resection 46 55 1728 1737 I-treatment
of 56 58 1738 1740 O
the 59 62 1741 1744 O
recurrent 63 72 1745 1754 O
tumor 73 78 1755 1760 B-cancer
and 79 82 1761 1764 O
have 83 87 1765 1769 O
no 88 90 1770 1772 O
evidence 91 99 1773 1781 O
of 100 102 1782 1784 O
residual 103 111 1785 1793 O
disease 112 119 1794 1801 O
evaluable 120 129 1802 1811 O
clinically 130 140 1812 1822 O
and 141 144 1823 1826 O
by 145 147 1827 1829 O
CT 148 150 1830 1832 B-treatment
or 151 153 1833 1835 O
MRI 154 157 1836 1839 B-treatment
imaging 158 165 1840 1847 I-treatment
, 165 166 1847 1848 O
following 167 176 1849 1858 O
resection 177 186 1859 1868 O

Patients 0 8 1869 1877 O
who 9 12 1878 1881 O
received 13 21 1882 1890 O
chemotherapy 22 34 1891 1903 B-treatment
directed 35 43 1904 1912 O
at 44 46 1913 1915 O
the 47 50 1916 1919 O
present 51 58 1920 1927 O
recurrence 59 69 1928 1938 O

Patients 0 8 1939 1947 O
with 9 13 1948 1952 O
GOG 14 17 1953 1956 B-clinical_variable
performance 18 29 1957 1968 I-clinical_variable
grade 30 35 1969 1974 O
of 36 38 1975 1977 O
3 39 40 1978 1979 B-lower_bound
or 41 43 1980 1982 O
4 44 45 1983 1984 B-upper_bound

Patients 0 8 1985 1993 O
with 9 13 1994 1998 O
a 14 15 1999 2000 O
history 16 23 2001 2008 O
of 24 26 2009 2011 O
other 27 32 2012 2017 O
invasive 33 41 2018 2026 B-cancer
malignancies 42 54 2027 2039 I-cancer

Patients 0 8 2040 2048 O
with 9 13 2049 2053 O
history 14 21 2054 2061 O
of 22 24 2062 2064 O
active 25 31 2065 2071 O
collagen 32 40 2072 2080 B-chronic_disease
vascular 41 49 2081 2089 I-chronic_disease
disease 50 57 2090 2097 I-chronic_disease

Patients 0 8 2098 2106 O
with 9 13 2107 2111 O
renal 14 19 2112 2117 B-chronic_disease
abnormalities 20 33 2118 2131 I-chronic_disease
, 33 34 2131 2132 O
such 35 39 2133 2137 O
as 40 42 2138 2140 O
pelvic 43 49 2141 2147 B-treatment
kidney 50 56 2148 2154 I-treatment
, 56 57 2154 2155 I-treatment
horseshoe 58 67 2156 2165 I-treatment
kidney 68 74 2166 2172 I-treatment
, 74 75 2172 2173 I-treatment
or 76 78 2174 2176 I-treatment
renal 79 84 2177 2182 I-treatment
transplantation 85 100 2183 2198 I-treatment
, 100 101 2198 2199 O
that 102 106 2200 2204 O
would 107 112 2205 2210 O
require 113 120 2211 2218 O
modification 121 133 2219 2231 O
of 134 136 2232 2234 O
radiation 137 146 2235 2244 O
fields 147 153 2245 2251 O

Patients 0 8 2252 2260 O
with 9 13 2261 2265 O
septicemia 14 24 2266 2276 B-chronic_disease
or 25 27 2277 2279 O
severe 28 34 2280 2286 B-chronic_disease
infection 35 44 2287 2296 I-chronic_disease

Patients 0 8 2297 2305 O
with 9 13 2306 2310 O
ureteral 14 22 2311 2319 B-chronic_disease
obstruction 23 34 2320 2331 I-chronic_disease
must 35 39 2332 2336 O
undergo 40 47 2337 2344 O
stent 48 53 2345 2350 B-treatment
or 54 56 2351 2353 O
nephrostomy 57 68 2354 2365 B-treatment
tube 69 73 2366 2370 I-treatment
placement 74 83 2371 2380 I-treatment
prior 84 89 2381 2386 O
to 90 92 2387 2389 O
study 93 98 2390 2395 O
entry 99 104 2396 2401 O

Platelets 0 9 2402 2411 B-clinical_variable
> 10 11 2412 2413 O
= 11 12 2413 2414 O
100,000 13 20 2415 2422 B-upper_bound
/ 20 21 2422 2423 I-lower_bound
mm^3 21 25 2423 2427 I-lower_bound
, 25 26 2427 2428 O
equivalent 27 37 2429 2439 O
to 38 40 2440 2442 O
CTCAE 41 46 2443 2448 B-clinical_variable
v 47 48 2449 2450 I-clinical_variable
3.0 49 52 2451 2454 I-clinical_variable
grade 53 58 2455 2460 I-clinical_variable
0 59 60 2461 2462 O
- 60 61 2462 2463 O
1 61 62 2463 2464 O

Primary 0 7 2465 2472 O
surgical 8 16 2473 2481 B-treatment
debulking 17 26 2482 2491 I-treatment
before 27 33 2492 2498 O
protocol 34 42 2499 2507 B-treatment
therapy 43 50 2508 2515 I-treatment
is 51 53 2516 2518 O
permissible 54 65 2519 2530 O
; 65 66 2530 2531 O
this 67 71 2532 2536 O
would 72 77 2537 2542 O
include 78 85 2543 2550 O
removal 86 93 2551 2558 O
of 94 96 2559 2561 O
gross 97 102 2562 2567 O
symptomatic 103 114 2568 2579 B-treatment
disease 115 122 2580 2587 I-treatment
in 123 125 2588 2590 O
the 126 129 2591 2594 O
pelvis 130 136 2595 2601 O
and/or 137 143 2602 2608 O
vagina 144 150 2609 2615 O

Serum 0 5 2616 2621 B-clinical_variable
glutamic 6 14 2622 2630 I-clinical_variable
oxaloacetic 15 26 2631 2642 I-clinical_variable
transaminase 27 39 2643 2655 I-clinical_variable
( 40 41 2656 2657 I-clinical_variable
SGOT 41 45 2657 2661 I-clinical_variable
) 45 46 2661 2662 I-clinical_variable
= 47 48 2663 2664 O
< 48 49 2664 2665 O
2.5 50 53 2666 2669 B-upper_bound
x 54 55 2670 2671 I-upper_bound
ULN 56 59 2672 2675 I-upper_bound
( 60 61 2676 2677 O
CTCAE 61 66 2677 2682 O
v 67 68 2683 2684 O
3.0 69 72 2685 2688 O
grade 73 78 2689 2694 O
0 79 80 2695 2696 O
- 80 81 2696 2697 O
1 81 82 2697 2698 O
) 82 83 2698 2699 O

a 0 1 2700 2701 O
CT 2 4 2702 2704 B-treatment
of 5 7 2705 2707 O
the 8 11 2708 2711 O
pelvis 12 18 2712 2718 O
and 19 22 2719 2722 O
abdomen 23 30 2723 2730 O
with 31 35 2731 2735 O
IV 36 38 2736 2738 O
and 39 42 2739 2742 O
oral 43 47 2743 2747 O
( 48 49 2748 2749 O
PO 49 51 2749 2751 O
) 51 52 2751 2752 O
contrast 53 61 2753 2761 O
performed 62 71 2762 2771 O
using 72 77 2772 2777 O
multi 78 83 2778 2783 O
- 83 84 2783 2784 O
detector 84 92 2784 2792 O
CT 93 95 2793 2795 O
and 96 99 2796 2799 O
equal 100 105 2800 2805 O
or 106 108 2806 2808 O
less 109 113 2809 2813 O
than 114 118 2814 2818 O
5 119 120 2819 2820 B-upper_bound
mm 121 123 2821 2823 I-upper_bound
slice 124 129 2824 2829 O
thickness 130 139 2830 2839 O

complete 0 8 2840 2848 O
workup 9 15 2849 2855 O
staging 16 23 2856 2863 O
should 24 30 2864 2870 O
be 31 33 2871 2873 O
performed 34 43 2874 2883 O
prior 44 49 2884 2889 O
to 50 52 2890 2892 O
initiation 53 63 2893 2903 O
of 64 66 2904 2906 O
therapy 67 74 2907 2914 B-treatment
to 75 77 2915 2917 O
rule 78 82 2918 2922 O
- 82 83 2922 2923 O
out 83 86 2923 2926 O
presence 87 95 2927 2935 O
of 96 98 2936 2938 O
metastatic 99 109 2939 2949 B-cancer
disease 110 117 2950 2957 I-cancer

computed 0 8 2958 2966 B-treatment
tomography 9 19 2967 2977 I-treatment
( 20 21 2978 2979 I-treatment
CT 21 23 2979 2981 I-treatment
) 23 24 2981 2982 I-treatment
scan 25 29 2983 2987 I-treatment
of 30 32 2988 2990 I-treatment
the 33 36 2991 2994 I-treatment
thorax 37 43 2995 3001 I-treatment
with 44 48 3002 3006 I-treatment
IV 49 51 3007 3009 I-treatment
contrast 52 60 3010 3018 I-treatment

if 0 2 3019 3021 O
the 3 6 3022 3025 O
patient 7 14 3026 3033 O
is 15 17 3034 3036 O
unable 18 24 3037 3043 O
to 25 27 3044 3046 O
tolerate 28 36 3047 3055 O
contrast 37 45 3056 3064 O
, 45 46 3064 3065 O
then 47 51 3066 3070 O
magnetic 52 60 3071 3079 B-treatment
resonance 61 70 3080 3089 I-treatment
imaging 71 78 3090 3097 I-treatment
( 79 80 3098 3099 I-treatment
MRI 80 83 3099 3102 I-treatment
) 83 84 3102 3103 I-treatment
with 85 89 3104 3108 I-treatment
IV 90 92 3109 3111 I-treatment
gadolinium 93 103 3112 3122 I-treatment
should 104 110 3123 3129 O
be 111 113 3130 3132 O
performed 114 123 3133 3142 O

no 0 2 3143 3145 O
evidence 3 11 3146 3154 O
of 12 14 3155 3157 O
extrapelvic 15 26 3158 3169 B-chronic_disease
disease 27 34 3170 3177 I-chronic_disease

patients 0 8 3178 3186 O
are 9 12 3187 3190 O
also 13 17 3191 3195 O
excluded 18 26 3196 3204 O
if 27 29 3205 3207 O
their 30 35 3208 3213 O
previous 36 44 3214 3222 O
cancer 45 51 3223 3229 B-treatment
treatment 52 61 3230 3239 I-treatment
contraindicates 62 77 3240 3255 O
this 78 82 3256 3260 O
protocol 83 91 3261 3269 O
therapy 92 99 3270 3277 B-treatment

patients 0 8 3278 3286 O
must 9 13 3287 3291 O
not 14 17 3292 3295 O
have 18 22 3296 3300 O
received 23 31 3301 3309 O
neoadjuvant 32 43 3310 3321 B-treatment
chemotherapy 44 56 3322 3334 I-treatment
for 57 60 3335 3338 O
the 61 64 3339 3342 O
present 65 72 3343 3350 O
recurrent 73 82 3351 3360 O
disease 83 90 3361 3368 O

patients 0 8 3369 3377 O
with 9 13 3378 3382 O
complete 14 22 3383 3391 O
resection 23 32 3392 3401 B-treatment
of 33 35 3402 3404 O
gross 36 41 3405 3410 O
recurrent 42 51 3411 3420 O
disease 52 59 3421 3428 O

